Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: The Procter & Gamble Company €3.25bn 4yr, 8yr, 12yr & 20yr Sr Unsec; MS+38bp / MS+70bp / MS+90bp / MS+120bp

IGC European Market: Deal Flow - General

Issuer

Term

Coupon

Maturity

Size

Ranking

Type

Price

Yield

Spread

IPT-PXD

ISIN

The Procter & Gamble Company

4yr

3.75%

03-Nov-30

€750m

Sr Unsec

Fixed

99.865

3.787%

MS+38

-27

XS3553990360

The Procter & Gamble Company

8yr

4.1%

03-Nov-34

€1bn

Sr Unsec

Fixed

99.859

4.121%

MS+70

-25

XS3553990444

The Procter & Gamble Company

12yr

4.25%

03-Nov-38

€750m

Sr Unsec

Fixed

98.87

4.373%

MS+90

-25

XS3553990527

The Procter & Gamble Company

20yr

4.625%

03-Nov-46

€750m

Sr Unsec

Fixed

99.564

4.659%

MS+120

-25

XS3553990790


Reoffer: 4yr: MS+38bp / 99.865 / 3.787% 8yr: MS+70bp / 99.859 / 4.121% 12yr: MS+90bp / 98.87 / 4.373% 20yr: MS+120bp / 99.564 / 4.659%

Tranche 1 (4yr): Final Books > €1.8bn
Tranche 2 (8yr): Final Books > €2.1bn
Tranche 3 (12yr): Final Books > €1.7bn
Tranche 4 (20yr): Final Books > €2.5bn

Launched:
4yr: €750m @ MS+38bp
8yr: €1bn @ MS+70bp
12yr: €750m @ MS+90bp
20yr: €750m @ MS+120bp
IPTs: 4yr: MS+65a 8yr: MS+95a 12yr: MS+115a 20yr: MS+145a


  • Issuer: The Procter & Gamble Company
  • Ticker: PG
  • LEI: 2572IBTT8CCZW6AU4I41
  • Expected Ratings: Aa3 (Positive) / AA- (Stable) (Moody's/S&P)
  • Format: Senior Unsecured Notes
  • Pricing Date: 27-Oct-26
  • Settlement: 03-Nov-26 (T+5)
  • Size:
    • 4yr: €750m
    • 8yr: €1bn
    • 12yr: €750m
    • 20yr: €750m
  • Maturity:
    • 4yr: 03-Nov-30
    • 8yr: 03-Nov-34
    • 12yr: 03-Nov-38
    • 20yr: 03-Nov-46
  • Coupon:
    • 4yr: 3.75%
    • 8yr: 4.1%
    • 12yr: 4.25%
    • 20yr: 4.625%
  • Interest: Fixed, Annual, ACT/ACT (ICMA) for all tranches
  • Reoffer:
    • 4yr: MS+38bp / 99.865
    • 8yr: MS+70bp / 99.859
    • 12yr: MS+90bp / 98.87
    • 20yr: MS+120bp / 99.564
  • Benchmark:
    • 4yr: OBL 2.2 10-Oct-30 / B+65.9bp
    • 8yr: DBR 2.6 15-Aug-34 / B+85.3bp
    • 12yr: DBR 1 15-May-38 / B+90.7bp
    • 20yr: DBR 2.5 15-Aug-46 / B+99bp
  • Optional Redemption: MWC for all tranches
  • ISIN / Common Code:
    • 4yr: XS3553990360 / 355399036
    • 8yr: XS3553990444 / 355399044
    • 12yr: XS3553990527 / 355399052
    • 20yr: XS3553990790 / 355399079
  • Hedge Details:
    • 4yr: EUR 4yr vs. OBL 2.2 10-Oct-30 (HR: 102%)
    • 8yr: EUR 8yr vs. DBR 2.6 15-Aug-34 (HR: 102%)
    • 12yr: EUR 12yr vs. DBR 1 15-May-38 (HR: 114%)
    • 20yr: EUR 20yr vs. DBR 2.5 15-Aug-46 (HR: 103%)
  • Hedge Deadline: 15.00 UKT
  • B&D: DB for all tranches
  • Timing: Books open, Today's business
  • Books Subject: 12.50 UKT
  • Joint Book-Running Managers: Citi / DB (B&D) / GS / HSBC / MS
  • Target Market: MiFID II and UK MiFIR professionals / ECPs-only / No PRIIPs KID or DISC Disclosure Document
  • Stabilization: FCA / ICMA
  • Selling Restrictions: As per The Procter & Gamble Companys Preliminary Prospectus Supplement
  • Clearing: Euroclear and Clearstream
  • Docs: SEC Registered / New York Stock Exchange Listing / New York Law
  • Denominations: €100,000 x €1,000
  • UoP: General Corporate Purposes
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.